Ir para o conteúdo principal

United StatesÚltimas notícias

Grafa
Health

AngioDynamics reports 8.8% revenue growth driven by high-margin med tech surge

AngioDynamics (NASDAQ:ANGO) on Tuesday reported fiscal second-quarter results that highlighted continued momentum in its high-margin Med Tech portfolio, with overall net sales rising 8.8% year over year to $79.4 million for the period ended Nov. 30, 2025.

Leia mais: AngioDynamics reports 8.8% revenue growth driven by high-margin med tech surge
Grafa
Technology

Himax and Vuzix unveil "prescription-ready" AR optical design ahead of CES 2026

Himax Technologies (NASDAQ:HIMX) and Vuzix Corporation (NASDAQ:VUZI) have jointly introduced a new optical reference design for augmented reality (AR) glasses, marking a major step toward making smart eyewear as wearable as traditional frames.

Leia mais: Himax and Vuzix unveil "prescription-ready" AR optical design ahead of CES 2026
Grafa
Health

FDA grants breakthrough status to oculis neuroprotective therapy for optic neuritis

Oculis Holding AG (NASDAQ:OCS) shares climbed today after the U.S. Food and Drug Administration (FDA) granted Breakthrough Therapy Designation to Privosegtor (OCS-05), a first-in-class neuroprotective candidate for the treatment of optic neuritis.

The designation, announced January 6, 2026, marks a major milestone for the Swiss biotech as it targets a $7 billion U.S. market for optic neuropathies.

Leia mais: FDA grants breakthrough status to oculis neuroprotective therapy for optic neuritis
Grafa
Industrials

Calumet sees strong adjusted EBITDA in 2025 despite net loss

Calumet (NASDAQ:CLMT) released a preliminary fiscal 2025 update on Tuesday, signaling a major turning point in its effort to repair a stretched balance sheet.

Despite projecting a net loss between $69 million and $12 million, the Indianapolis-based specialty products maker highlighted a significant reduction in restricted debt and a "transformed" outlook for its high-growth renewable energy subsidiary.

Leia mais: Calumet sees strong adjusted EBITDA in 2025 despite net loss
Grafa

Broadridge expands global reach with acquisition of Zurich-based Acolin

Broadridge Financial Solutions (NYSE:BR) has completed its acquisition of Acolin, a Zurich-based leader in cross-border fund distribution and regulatory services.

The deal, finalized on January 6, 2026, significantly bolsters Broadridge’s footprint in the European asset management market and integrates specialized compliance technology into its global fintech stable.

Leia mais: Broadridge expands global reach with acquisition of Zurich-based Acolin